ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Cullinan Therapeutics Inc

Cullinan Therapeutics Inc (CGEM)

12.68
0.29
(2.34%)
At close: January 03 4:00PM
12.68
-0.019
( -0.15% )
After Hours: 4:04PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
12.68
Bid
12.50
Ask
13.55
Volume
290,627
12.515 Day's Range 12.985
9.95 52 Week Range 30.1886
Market Cap
Previous Close
12.39
Open
12.565
Last Trade
1
@
12.68
Last Trade Time
16:05:00
Financial Volume
$ 3,699,715
VWAP
12.7301
Average Volume (3m)
526,586
Shares Outstanding
58,227,593
Dividend Yield
-
PE Ratio
-4.83
Earnings Per Share (EPS)
-2.63
Revenue
-
Net Profit
-153.16M

About Cullinan Therapeutics Inc

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Cullinan Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CGEM. The last closing price for Cullinan Therapeutics was $12.39. Over the last year, Cullinan Therapeutics shares have traded in a share price range of $ 9.95 to $ 30.1886.

Cullinan Therapeutics currently has 58,227,593 shares outstanding. The market capitalization of Cullinan Therapeutics is $721.44 million. Cullinan Therapeutics has a price to earnings ratio (PE ratio) of -4.83.

CGEM Latest News

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2-1.5527950310612.8812.9511.7580938412.11692463CS
40.161.2779552715712.5213.610.4454503911.99233032CS
12-3.21-20.201384518615.8917.97510.4452658613.88794604CS
26-3.78-22.96476306216.4621.0110.4458692316.18424043CS
522.0919.735599622310.5930.18869.9563420418.21256416CS
156-3.02-19.235668789815.730.18867.337842515.11624258CS
260-29.32-69.80952380954259.857.335071317.82503229CS

CGEM - Frequently Asked Questions (FAQ)

What is the current Cullinan Therapeutics share price?
The current share price of Cullinan Therapeutics is $ 12.68
How many Cullinan Therapeutics shares are in issue?
Cullinan Therapeutics has 58,227,593 shares in issue
What is the market cap of Cullinan Therapeutics?
The market capitalisation of Cullinan Therapeutics is USD 721.44M
What is the 1 year trading range for Cullinan Therapeutics share price?
Cullinan Therapeutics has traded in the range of $ 9.95 to $ 30.1886 during the past year
What is the PE ratio of Cullinan Therapeutics?
The price to earnings ratio of Cullinan Therapeutics is -4.83
What is the reporting currency for Cullinan Therapeutics?
Cullinan Therapeutics reports financial results in USD
What is the latest annual profit for Cullinan Therapeutics?
The latest annual profit of Cullinan Therapeutics is USD -153.16M
What is the registered address of Cullinan Therapeutics?
The registered address for Cullinan Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Cullinan Therapeutics website address?
The website address for Cullinan Therapeutics is www.cullinantherapeutics.com
Which industry sector does Cullinan Therapeutics operate in?
Cullinan Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MEGLMagic Empire Global Limited
$ 0.79
(40.54%)
2.42M
PTLEPTL Ltd
$ 10.30
(39.38%)
97.09k
PWMPrestige Wealth Inc
$ 1.58
(36.21%)
187.85k
MBOTMicrobot Medical Inc
$ 2.60
(21.50%)
3.09M
KITTNauticus Robotics Inc
$ 4.59
(20.79%)
4.06M
ACONAclarion Inc
$ 0.2001
(-32.94%)
5.61M
RAINRain Enhancement Technologies Holdco Inc
$ 4.97
(-14.90%)
9.52k
MMVMultiMetaVerse Holdings Ltd
$ 0.90
(-14.69%)
3.25k
CVKDCadrenal Therapeutics Inc
$ 13.5364
(-14.60%)
7.18k
QSIQuantum Si Inc
$ 3.9101
(-8.86%)
7.07M
QSIQuantum Si Inc
$ 3.9101
(-8.86%)
7.07M
VEEETwin Vee PowerCats Company
$ 0.5602
(13.63%)
5.72M
ACONAclarion Inc
$ 0.2001
(-32.94%)
5.61M
TGLTreasure Global Inc
$ 0.4025
(3.21%)
5.32M
NVDANVIDIA Corporation
$ 144.53
(0.04%)
4.5M

Your Recent History

Delayed Upgrade Clock